Multiple Sclerosis Group, Biodonostia Health Research Institute, 20014 San Sebastian, Spain.
Multiple Sclerosis Group, Biodonostia Health Research Institute, 20014 San Sebastian, Spain; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisboa, Portugal.
Mult Scler Relat Disord. 2022 Jul;63:103836. doi: 10.1016/j.msard.2022.103836. Epub 2022 May 11.
Experimental autoimmune encephalomyelitis (EAE) is the most widely used animal model for multiple sclerosis (MS). It is a rapid model, commonly induced in rodents. Even if EAE does not replicate all MS characteristics, it is appropriate to investigate the development of the disease, including the immune and neuroinflammatory aspects. Besides, EAE has also been shown to be a relevant model for pre-clinical studies, as several drugs effective in the model are beneficial for MS patients. However, despite its widespread use, there is no consensus on the clinical assessment of animals. Most researchers perform a daily evaluation and classify them on a 5-point scale, but many authors also use in-between scores or apply other systems. Besides, among the 5-point scale, different score definitions are used, and most of them do not recapitulate the signs or symptoms each animal can show. Thus, based on our experience with EAE, the aim of the present work was to develop a new scoring system.
We designed the "I AM D EAE" tool that independently evaluates 9 different items - an innovative and detailed scoring system, yet simple for non-experts to use. The new scale was tested in EAE-induced mice at three experiments, and different evaluators assessed the animals blindly.
The "I AM D EAE" scoring system highly correlates to the commonly used 5-point scale and, importantly, it enables a more detailed evaluation.
Considering its high reproducibility and inter-rater reliability, "I AM D EAE" is a useful tool for EAE monitoring.
实验性自身免疫性脑脊髓炎(EAE)是最常用于多发性硬化症(MS)的动物模型。它是一种快速模型,通常在啮齿动物中诱导。即使 EAE 不能复制所有 MS 的特征,它也适合于研究疾病的发展,包括免疫和神经炎症方面。此外,EAE 也被证明是临床前研究的一个相关模型,因为在模型中有效的几种药物对 MS 患者有益。然而,尽管它被广泛应用,但对动物的临床评估仍未达成共识。大多数研究人员每天进行评估,并将其分为 5 分制,但许多作者也使用中间评分或应用其他系统。此外,在 5 分制中,使用不同的评分定义,而且大多数评分都不能概括每个动物可能表现出的体征或症状。因此,基于我们在 EAE 方面的经验,本研究的目的是开发一种新的评分系统。
我们设计了“I AM D EAE”工具,该工具独立评估 9 个不同项目——这是一个创新且详细的评分系统,对于非专家来说也很简单易用。新的评分系统在三个实验中对诱导 EAE 的小鼠进行了测试,不同的评估者对动物进行了盲法评估。
“I AM D EAE”评分系统与常用的 5 分制高度相关,重要的是,它能够进行更详细的评估。
考虑到其高重现性和评分者间可靠性,“I AM D EAE”是监测 EAE 的有用工具。